Intra-Cellular Therapies (ITCI) 10-Q2016 Q1 Quarterly report

Filed: 28 Apr 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accrual, affinity, America, antidepressant, approach, arising, ASU, authoritative, checklist, classification, clinician, consummation, counterparty, decided, differentiated, distinguishing, dopaminergic, dual, employee, expert, glutamatergic, holder, illustrate, issuer, match, matching, meant, mediate, mesolimbic, mood, multiple, NMDA, offsetting, outlook, pattern, phosphorylation, progression, psychosocial, recovery, regional, Restated, reuptake, RSU, schizoaffective, serotonergic, simplification, site, stimulate, thought, variability

Removed: accredited, acquire, acquirer, acted, acutely, adding, adequately, adjusted, allocable, bearing, began, ceased, Chairman, Chief, comprise, continuing, conversion, corporation, Cowen, dated, declared, eleven, eligible, emerging, enhance, exacerbated, exchanged, Excluding, exercisable, filing, final, formed, growth, Guggenheim, improve, initial, institutional, invested, investigation, involvement, JMP, joint, jointly, landlord, Leerink, LLC, local, member, moved, offer, offered, parent, percent, placement, policy, preservation, President, proceeding, promissory, promulgated, redeemable, redemption, refine, registered, registration, remain, represented, retrospectively, Rule, secure, seeking, senior, transaction, utilize, variety, vast, vehicle, voting, warranted, wider

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ITCI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended March 31, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: April 28, 2016						/s/ Sharon Mates, Ph.D.
						Sharon Mates, Ph.D.
						Chairman, President and Chief Executive Officer (principal executive officer)

Dated: April 28, 2016						/s/ Lawrence J. Hineline
						Lawrence J. Hineline
						Vice President of Finance and Chief Financial Officer (principal financial officer)